TANG CAPITAL PARTNERS LP 13D/13G Filings for Albireo Pharma, Inc. (ALBO)

TANG CAPITAL PARTNERS LP 13D and 13G filings for Albireo Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
4:00 pm
Sale		 2022-12-31 13G Albireo Pharma, Inc.
ALBO		 TANG CAPITAL PARTNERS LP 411,968
2.000%		 -687,548decrease
(-62.53%)		 Filing
2022-09-26
4:00 pm
Purchase		 2022-09-15 13G Albireo Pharma, Inc.
ALBO		 TANG CAPITAL PARTNERS LP 1,099,516
5.600%		 1,099,516increase
(New Position)		 Filing